Journal of Urology

Papers
(The TQCC of Journal of Urology is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
MP15-18 MOLECULAR CHARACTERIZATION OF URETHRAL CANCER AND COMPARISON WITH BLADDER CANCER443
PD51-08 SREBP1 INDUCES RESISTANCE TO HIF-2α ANTAGONIST IN CLEAR CELL RENAL CELL CARCINOMA300
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter.251
PD47-12 DOES ANESTHESIA TYPE MATTER IN SHOCKWAVE LITHOTRIPSY?210
MP33-08 OPIOID PRESCRIBING PATTERNS AND POST-PROSTATECTOMY READMISSION196
Editorial Comment193
PD35-04 OPEN VS. ROBOTIC-ASSISTED RECONSTRUCTION IN VESICOURETHRAL ANASTOMOTIC STENOSIS180
MP22-04 MAINTENANCE OF SKELETAL MUSCLES WHEN RECEIVING NEOADJUVANT CHEMOTHERAPY IMPROVES THE PROGNOSIS FOR PATIENTS WITH MUSCLE INVASIVE BLADDER CANCER166
PD33-08 BACTERIAL BIOFILMS FROM INDWELLING SACRAL NEUROMODULATION DEVICES ARE RECONSTITUTABLE IN VITRO AND EXHIBIT DIFFERENTIAL FORMATION BY MATERIAL TYPE165
V02-10 LIMITED RESOURCES IMPROVISED BASKETS FOR PCNL156
MP67-12 FIRST LOOK: LASER SPECKLE IMAGING IS A NOVEL METHOD TO IDENTIFY AND PRESERVE NEUROVASCULAR BUNDLE DURING ROBOTIC ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY147
PD23-04 URINARY PROTEINS IN THE DIAGNOSIS OF MIXED INTRINSIC SPHINCTER DEFICIENCY AND DETRUSOR OVERACTIVITY IN FEMALE PATIENTS WITH STRESS URINARY INCONTINENCE?131
PD32-07 RACE MODIFIED ESTIMATED GLOMERULAR FILTRATION RATE UNDERESTIMATES CHRONIC KIDNEY DISEASE PREVALENCE IN AFRICAN-AMERICAN PATIENTS UNDERGOING PARTIAL AND RADICAL NEPHRECTOMY: IMPLICATIONS FOR SU124
MP64-20 UNDERSTANDING CLINICAL OUTCOMES IN PATIENTS RENDERED NO EVIDENCE OF DISEASE IN METASTATIC RENAL CELL CARCINOMA123
PD12-11 URETHRAL COMPLICATIONS AFTER METOIDIOPLASTY WITH URETHRAL RECONSTRUCTION108
PD27-02  99m TC-PSMA RADIOGUIDED SURGERY USING A DROP-IN GAMMA PROBE IN RADICAL PROSTATECTOMY: INITIAL RESULTS105
MP11-08 EXPLORING THE EFFECT OF METASTASIS DIRECTED THERAPY ON PROGRESSION PATTERNS OF PATIENTS WITH POSITIVE 68Ga-PSMA PET/CT AND BIOCHEMICAL RECURRENCE FROM PROSTATE CANCER102
V04-06 ROBOTIC ASSISTED TRANS-VESICOSCOPIC URETERIC REIMPLANTATION IN CHILDREN: SURGICAL ERGONOMICS RELATED TO MUSCULOSKELETAL SYMPTOMS88
PD08-12 PREDICTORS OF PROGRESSION AND DELAYED INTERVENTION IN SMALL RENAL MASS PATIENTS UNDERGOING ACTIVE SURVEILLANCE WITHOUT HEALTH-RELATED SELECTION BIAS88
MP53-20 INITIAL UROLOGIC EVALUATION FOR ANORECTAL MALFORMATIONS: A PCPLC RETROSPECTIVE81
MP28-03 CYTOREDUCTIVE NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITORS IS SAFE AND FACILITATES TREATMENT FREE INTERVALS74
V07-07 WIRE-GUIDED EXTRAVESICAL ROBOT-ASSISTED BLADDER DIVERTICULECTOMY AND Y-V PLASTY FOR RECURRENT BLADDER NECK STRICTURE71
LBA01-08 EFFICACY OF TARGETED MAST CELL INHIBITION THERAPY IN CHRONIC PROSTATITIS/CHRONIC PELVIC PAIN SYNDROME67
PD04-08 BALIXAFORTIDE, A CXCR4 INHIBITOR, SYNERGIZES WITH DOCETAXEL TO DIMINISH TUMOR GROWTH IN A PROSTATE CANCER MODEL OF BONE METASTASIS66
PD43-02 FUNCTIONAL OUTCOMES AFTER SELECTIVE CLAMPING IN ROBOT-ASSISTED PARTIAL NEPHRECTOMY65
MP48-04 PERSPECTIVES OF SOCIETY OF WOMEN IN UROLOGY MEMBERS TOWARD DOBBS V. JACKSON WOMEN′S HEALTH ORGANIZATION64
MP38-19 FOCAL THERAPY CANDIDACY: AN EVALUATION OF INITIAL AND CONTINUED ELIGIBILITY FOR FOCAL THERAPY IN AN ACTIVE SURVEILLANCE COHORT62
MP66-14 WEBSITE TRANSPARENCY AND INFORMATION DISSEMINATION AMONG UROLOGY RESIDENCY PROGRAMS57
PD39-07 CAN WE STOP DOING SYSTEMATIC BIOPSIES IN MEN WITH PIRADS/LIKERT 5 LESIONS ON MULTI PARAMETRIC MAGNETIC RESONANCE IMAGING? AN ANALYSIS FROM A MULTICENTRE PROSPECTIVE DATASET OF OVER 800 PATIENT55
PD17-03 REDOX IMBALANCE AND MAPK ACTIVATION MEDIATES PNEUMOPERITONEUM-INDUCED KIDNEY INJURY DURING MINIMALLY INVASIVE SURGERY54
MP57-02 AN UPDATE ON PROFESSIONAL BURNOUT AND CONFLICT-WORK FROM THE AUA WORKFORCE WORKGROUP53
MP12-03 IMPLICATIONS OF RACE FREE RENAL FUNCTION EQUATIONS ON BLACK PATIENTS WITH RENAL CELL CARCINOMA52
HF02-04 KEEPING IT REEL: PHOTOGRAPHY AND CINEMATOGRAPHY IN UROLOGY52
MP30-02 A NOVEL PREDICTION MODEL FOR POSSIBILITY OF SPERM RETRIEVAL IN MICRO TESE FOR NON-OBSTRUCTIVE AZOOSPERMIA PATIENTS USING AUTOMATED ARTIFICIAL INTELLIGENCE51
PD24-03 BEST TREATMENT FOR OLIGOMETASTATIC RENAL CANCER: A QUASI-INDIVIDUAL PATIENT DATA ANALYSIS51
MP62-05 AUA RECOMMENDED ANTIBIOTIC PROPHYLAXIS FOR PRIMARY PENILE IMPLANTATION RESULTS IN A HIGHER, NOT LOWER, RISK FOR POST-OPERATIVE INFECTION: A MULTICENTER ANALYSIS50
MP36-04 PREDICTORS OF PENILE PLICATION AFTER INTRALESIONAL COLLAGENASE CLOSTRIDIUM HISTOLYTICUM INJECTION IN MEN WITH PEYRONIE’S DISEASE50
MP36-05 CLINIC SCORE - A NOVEL PREDICTION MODEL OF COLLAGENASE CLOSTRIDIUM HISTOLYTICUM OUTCOMES IN MEN WITH PEYRONIE’S DISEASE50
MP70-07 HIGH-PERFORMING SCALABLE EXTRACTION OF ELEMENTS OF URINARY TRACT DILATION CLASSIFICATION USING NATURAL LANGUAGE PROCESSING ALGORITHMS FOR NEONATAL ULTRASOUND REPORTS50
MP07-15 LANGUAGE-RELATED DISPARITIES IN ACUTE POSTOPERATIVE PAIN MANAGEMENT FOLLOWING PELVIC FLOOR RECONSTRUCTIVE SURGERY49
PD19-09 IMMUNOPROPHYLAXIS WITH AUTOVACCINE DECREASES HOSPITAL ADMISSIONS AND EMERGENCY ROOM VISITS IN PATIENTS WITH NEUROGENIC BLADDER49
PD14-12 SEXUAL FUNCTION IN WOMEN FOLLOWING TENSION-FREE VAGINAL TAPE-OBTURATOR PROCEDURE: A PROSPECTIVE STUDY47
MP02-03 FASCIOCUTANEOUS FLAP CLOSURE OF THE PERINEUM AS AN ALTERNATIVE TO SCROTOPLASTY FOR EXTENSIVE GENITAL TISSUE LOSS47
PD31-09 DEVELOPMENT OF EXTREME GRADIENT BOOST (XGBOOST) MACHINE LEARNING MODEL USING AN INSTITUTIONAL PEDIATRIC KIDNEY TRANSPLANT DATABASE FOR PREDICTION OF DELAYED GRAFT FUNCTION46
MP41-18 CLINICAL MANIFESTATIONS OF BIRT-HOGG-DUBE SYNDROME IN A LARGE CLINICAL COHORT46
Urological Oncology: Bladder, Penis and Urethral Cancer, and Basic Principles of Oncology46
Urological Oncology: Prostate Cancer44
Editorial Comment42
MP12-03 IL-7 AND CCL19 PRODUCING CAR-T CELLS PREVENT ANTIGEN-LOSS TUMOR RELAPSE AND ENHANCE ANTITUMOR EFFICACY AGAINST SOLID CANCER41
MP54-13 THE UPDATE FROM BLADDER CANCER ITALIAN ACTIVE SURVEILLANCE (BIAS) PROJECT FOR LOW-GRADE BLADDER TUMORS: LONG-TERM ONCOLOGICAL OUTCOMES OF PATIENTS UNDER ACTIVE SURVEILLANCE38
MP46-04 10-YEAR EXPERIENCE WITH MIDLINE EXTRAPERITONEAL RETROPERITONEAL LYMPH NODE DISSECTION37
PD35-06 HEALTH-RELATED QUALITY OF LIFE IN LOW-INCOME MEN AFTER SURGICAL CASTRATION FOR METASTATIC PROSTATE CANCER37
PD23-04 EXPLORING ACTINIDIN AS A NOVEL COLLAGENASE TO TREAT HUMAN PEYRONIE’S DISEASE CELLS37
MP21-16 DEMOGRAPHICS AND INCIDENTAL DIAGNOSES OF MEN WITH PRIAPISM37
PD40-10 FORMAL VALIDATION AT FINAL PATHOLOGY AFTER RADICAL NEHRECTOMY OF NEPHROMETRY SCORES: DISCORDANCE RATES AND OVERTREATMENT RISK37
MP40-04 PREDICTIVE RISK FACTORS FOR EARLY RECURRENCE AFTER RADICAL NEPHROURETERECTOMY FOR LOW-GRADE UPPER TRACT UROTHELIAL CARCINOMA35
MP21-11 SEVERITY OF PENILE CURVATURE IN PEYRONIE’S DISEASE DOES NOT CORRELATE WITH SHIM OR PDQ SCORES35
LBA02-02 DEVELOPMENT OF A MULTIPHASIC BLADDER PATCH COMPOSED OF COLLAGEN, AMNIOTIC MEMBRANE, AND PATIENT-DERIVED EPITHELIAL CELLS34
This Month in Adult Urology34
MP11-04 PELVIC ORGAN PROLAPSE IS NOT UNCOMMON AMONG WOMEN WITH SPINA BIFIDA33
PD39-05 PROSTATE MEASUREMENT ON COMPUTED TOMOGRAPHY: VARIANCE DECREASES AS PROSTATE VOLUME INCREASES33
V07-04 SINGLE PORT TRANSVESICAL PARTIAL PROSTATECTOMY FOR LOCALIZED PROSTATE CANCER32
Editorial Comment31
MP08-10 LATERALIZATION OF BLADDER FUNCTION IN NORMAL FEMALE CANINES30
MP41-01 IMPACT OF HISTOLOGICAL VARIANTS ON CLINICAL OUTCOMES IN PATIENTS WITH CHEMORESISTANT UROTHELIAL CANCER TREATED WITH PEMBROLIZUMAB: A PROPENSITY SCORE MATCHING ANALYSIS30
PD38-03 AN INITIATIVE TO REDUCE UNNECESSARY INPATIENT URINARY RETENTION CONSULTS30
Editorial Comment29
LBA02-02 INITIAL RESULTS FROM A PHASE 1/2 TRIAL OF LARGE SURFACE AREA MICROPARTICLE DOCETAXEL FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER29
A Year of Change, with More to Come29
MP56-11 REFRACTORY LOWER URINARY TRACT SYMPTOMS (LUTS) FOLLOWING SUCCESSFUL URETHROPLASTY: FURTHER EXAMINING "LUTS FAILURE”29
MP34-01 IS TESTIS SPARING SURGERY A SAFE APPROACH IN PATIENTS WITH SMALL TESTICULAR LESIONS REFERRING TO A FERTILITY CENTER? A RETROSPECTIVE ANALYSIS REPORTING LONG-TERM ONCOLOGICAL OUTCOMES AND FACTO29
MP10-09 USEFULNESS OF RESECTION PROCESS MAP IN RAPN FOR ENDOPHYTIC RENAL TUMORS AND DEVELOPMENT OF VIRTUAL REALITY SIMULATION28
PD57-10 OPTIMIZING THE NUMBER OF SYSTEMATIC CORES DURING AN MRI TARGET BIOPSY: PRELIMINARY RESULTS FROM THE PROSPECTIVE, SINGLE CENTER SCOT TRIAL (NCT 04183699)28
Editorial Comment28
MP23-01 ADDRESSING BURNOUT IN UROLOGY: A QUALITATIVE ASSESSMENT OF INTERVENTIONS28
PD16-03 THREE-DIMENSIONAL VIRTUAL MODELLING FOR ANATOMICAL COMPREHENSION OF RENAL ANATOMY: VALIDATION OF NEPHROMETRY SCORES BEFORE PARTIAL NEPHRECTOMY28
V01-09 ROBOTIC-ASSISTED CONTINENT CUTANEOUS DIVERSION: FEASIBILITY OF A ROBOTIC SPIRAL MONTI TECHNIQUE IN A PATIENT WITH INCOMPLETE EMPTYING28
MP31-07 THE EFFECT OF HORMONAL STIMULATION IN HYPOGONADAL MEN UNDERGOING MICROSURGICAL TESTICULAR SPERM RETRIEVAL (MTESE)28
PD41-09 VARIABILITY IN COST-EFFECTIVE PRICE POINTS FOR SINGLE-USE CYSTOSCOPES BASED ON PRACTICE VOLUME: A REAL-WORLD ANALYSIS OF TWO PRACTICES IN A MAJOR URBAN CENTER27
MP30-17 A DOUBLE BLIND, PROSPECTIVE STUDY FOR PROSTATE CANCER DIAGNOSIS IN URINE SAMPLE: ACCURACY OF THE ELECTRONIC NOSE COMPARED TO HIGHLY TRAINED DOGS27
MP04-16 CASE SERIES ON THE SURGICAL MANAGEMENT OF PENILE FOREIGN BODY INJECTIONS27
MP33-08 GUT MICROBIOTA PROFILE ASSOCIATED WITH HIGH-GRADE PROSTATE CANCER27
LBA02-03 A PHASE II RANDOMIZED CLINICAL TRIAL OF YOGA IN MEN WITH PROSTATE CANCER27
MP21-05 HOW FAR WILL THEY GO? DISTANCE AND DRIVING TIMES THAT NORTH AMERICAN MEN TRAVEL TO SEE A REPRODUCTIVE UROLOGIST26
PD01-02 COMPARATIVE ANALYSIS OF THE MICROBIOME OF INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME, CYSTITIS AND ASYMPTOMATIC HEALTHY CONTROLS: THE KEY TO INTERPRETATION OF NEXT GENERATION SEQUENCING URINE26
MP50-10 SHARED DECISION MAKING FOR LOCALIZED PROSTATE CANCER PATIENTS25
V11-01 LAPAROSCOPIC AND ROBOT-ASSISTED LEVEL II AND III INFERIOR VENA CAVA TUMOR THROMBECTOMY25
PD37-07 NEWLY DISCOVERED CHONDROITINASE HYAL4-V1 DRIVES GEMCITABINE RESISTANCE AND PREDICTS GEMCITABINE/CISPLATIN FAILURE IN BLADDER CANCER PATIENTS25
MP41-10 COMPUTED-TOMOGRAPHY BASED RISK STRATIFICATION TO PREDICT ONCOLOGICAL OUTCOME OF CLINICAL LYMPH NODE POSITIVE PATIENTS UNDERGOING RADICAL CYSTECTOMY25
MP67-07 TASK-SHIFTING CAN BE SAFELY CONDUCTED IN EARLY INFANT MALE CIRCUMCISION IN SUB-SAHARAN AFRICA: EXAMPLE FROM THE SHANGRING VERSUS MOGEN CLAMP RANDOMIZED CONTROLLED TRIAL25
MP17-14 COST-EFFECTIVENESS OF TRANSPERINEAL VERSUS TRANSRECTAL PROSTATE BIOPSY FOR THE DIAGNOSIS OF PROSTATE CANCER24
PD18-08 PRESERVATION OF SEXUAL FUNCTION 5-YEARS AFTER WATER VAPOR THERMAL THERAPY FOR BENIGN PROSTATIC HYPERPLASIA24
Editorial Comment24
MP37-17 PROTECTIVE EFFECT OF DAPAGLIFLOZIN AGAINST CYCLOSPORINE A-INDUCED NEPHROTOXICITY24
V01-11 ROBOT-ASSISTED SURGICAL REPAIR OF URETERO-ILEAL ANASTOMOTIC STRICTURE AFTER CYSTECTOMY AND ILEAL CONDUIT IN NEUROLOGICAL PATIENT23
MP31-11 WHAT IS THE PREDICTIVE VALUE OF A SPERMATIC CORD BLOCK PRIOR TO TARGETED MICROSURGICAL DENERVATION OF THE SPERMATIC CORD?23
V12-11 THE EFFECT OF VESICOPEXY ON URINARY CONTINENCE RECOVERY FOLLOWING ROBOTIC-ASSISTED RADICAL PROSTATECTOMY: TECHNIQUE AND OUTCOMES23
V10-11 INTRAOPERATIVE COMPLICATIONS OF ROBOTIC-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL URINARY DIVERSION23
MP52-07 RESULTS OF PERIURETHRAL ADJUSTABLE BALLOONS (ACT™) IN THE TREATMENT OF COMPLEX FEMALE STRESS URINARY INCONTINENCE23
MP66-07 BCG INVOKES SUPERIOR STING-MEDIATED INNATE IMMUNE RESPONSE OVER RADIOTHERAPY IN A CARCINOGEN MURINE MODEL OF UROTHELIAL CANCER23
MP34-05 ESTABLISHING AN ONCOLOGY FERTILITY PRESERVATION PROGRAM – AREAS OF IMPACT22
MP59-01 RENAL FUNCTION DETERIORATION ASSESSMENT IN TOTALLY ENDOPHYTIC DEEP RENAL MASSES TREATED WITH ROBOTIC PARTIAL NEPHRECTOMY: COMPARISON WITH A WHOLE COHORT OF CT1-2 RENAL TUMORS PATIENTS FROM A M22
MP21-03 INHIBIN B IS A PREDICTIVE FACTOR OF SPERM RECOVERY IN NON-OBSTRUCTIVE AZOOSPERMIA21
MP57-10 VIRTUAL LEARNING WITH REMOTE PROCTORING FOR INFLATABLE PENILE PROSTHESIS (IPP) TRAINING: A FEASIBILITY STUDY FOR SOCIALLY DISTANCED EDUCATION21
MP52-04 LONG-TERM OUTCOMES FROM THE REMEEX SYSTEM ® IN FEMALE PATIENTS WITH INTRINSIC SPHINCTERIC DEFICIENCY AND RECURRENT URINARY INCONTINENCE: DATA FROM A MINIMUM 21
MP42-06 PREDICTORS OF SURGICAL APPROACH IN THE MANAGEMENT OF LARGE RENAL MASSES: 20-YEAR SINGLE INSTITUTIONAL EXPERIENCE21
MP40-12 EXPERIENCE AND PRACTICE RECOMMENDATIONS FOR THE ROLE OF DSNB IN NON-PENILE GENITAL MALIGNANCY21
PD43-12 WHAT PART DOES URETEROSCOPY PLAY IN THE DIAGNOSTIC PATHWAY OF UPPER TRACT TRANSITIONAL CARCINOMA? A TWO-YEAR REVIEW IN A HIGH-VOLUME INSTITUTION21
MP60-09 GERMLINE TESTING FOR PROSTATE CANCER: WHICH REFERRAL METHOD IS BEST?21
PD06-07 EFFECT OF PULSE WIDTH VARIATIONS ON SACRAL NEUROMODULATION FOR OVERACTIVE BLADDER SYMPTOMS: A PROSPECTIVE RANDOMIZED CROSSOVER PILOT STUDY21
HF01-11 RETROSPECTROSCOPE UNDER THE MICROSCOPE: A FORENSIC EVALUATION OF THE 2020 AUA RETROSPECTROSCOPE AWARD WINNING PRESENTATION21
MP50-12 PELVIC LYMPH NODE DISSECTION AT RADICAL PROSTATECTOMY FOR INTERMEDIATE RISK PROSTATE CANCER: ASSESSING UTILITY AND NODAL METASTASES WITHIN A STATEWIDE QUALITY IMPROVEMENT CONSORTIUM21
MP32-10 RACIAL DIFFERENCES IN THE TREATMENT AND OUTCOMES FOR PROSTATE CANCER IN MASSACHUSETTS20
MP60-19 CELL-FREE DNA AND ANDROGEN RECEPTOR AMPLIFICATION CORRELATE WITH CLINICAL OUTCOMES IN CASTRATION-RESISTANT PROSTATE CANCER20
MP52-02 LONG-TERM EFFECT OF LOCAL AND SYSTEMIC ADIPOSE TISSUE-DERIVED STEM CELLS ON STRESS URINARY INCONTINENCE IN RATS20
MP20-01 #AUAMATCH: THE IMPACT OF COVID-19 ON SOCIAL MEDIA USE IN THE UROLOGY RESIDENCY MATCH19
PD57-02 NATIONAL CANCER DATABASE ANALYSIS ASSESSING THE IMPACT OF TREATMENT MODALITIES ON SURVIVAL OUTCOMES IN LOCALIZED NEUROENDOCRINE PROSTATE ADENOCARCINOMA19
V06-04 SALVAGE EN-BLOC THULIUM FIBER LASER ENUCLEATION OF PROSTATE FOR GIANT PROSTATOMEGALY AFTER PROSTATIC URETHRAL LIFT19
PD15-05 PROGNOSTIC VALUE OF EARLY DYNAMIC CHANGE OF NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IN PATIENTS WITH UPPER-TRACT UROTHELIAL CARCINOMA (UTUC) TREATED WITH NEPHROURETERECTOMY19
PD21-07 EFFECT OF A HIGH CITRATE BEVERAGE ON URINE CHEMISTRY IN KIDNEY STONE FORMERS19
PD58-08 SURVIVAL OUTCOMES IN SOLITARY KIDNEY PATIENTS DIAGNOSED WITH UPPER TRACT UROTHELIAL CARCINOMA18
MP26-09 ACCURACY OF DIAGNOSTIC CODES IN A CLINICAL RESEARCH NETWORK TO IDENTIFY PRIMARY HYPEROXALURIA PATIENTS18
MP58-16 DOES VETERAN STATUS MITIGATE RACIAL DISPARITIES IN PROSTATE CANCER SCREENING? ANALYSIS OF PROSTATE-SPECIFIC ANTIGEN SCREENING PATTERNS IN THE 2018 BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM DA18
MP17-03 COMPLICATION RATES AMONG DIFFERENT TREATMENT MODALITIES FOR THE SURGICAL MANAGEMENT OF VESICOURETERAL REFLUX IN CHILDREN18
MP05-16 NEW PERSPECTIVES ON AN OLD GROUPING: THE GENOMIC AND PHENOTYPIC DIFFERENCES OF OXALOBACTER FORMIGENES18
MP45-07 ONCOLOGIC OUTCOMES OF TOTAL LENGTH GLEASON PATTERN 4 ON BIOPSY IN MEN WITH GRADE GROUP 2 PROSTATE CANCER18
PD55-02 PREDICTION OF CHEMICAL COMPOSITION OF URINARY STONE THROUGH DEEP LEARNING18
PD08-02 URINARY DIVERSION FOR INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME: PREVALENCE AND PERIOPERATIVE COMPLICATION RATE18
PD18-08 PROGNOSTIC VALUE OF NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO FOR SMALL RENAL CELL CARCINOMAS AFTER IMAGE-GUIDED CRYOABLATION (CRYO) OR RADIO-FREQUENCY ABLATION (RFA)18
MP24-01 RACE BASED EQUATIONS FOR ESTIMATING KIDNEY FUNCTION MAY CONTRIBUTE TO RACIAL DISPARITIES IN PARTIAL NEPHRECTOMY UTILIZATION AMONG BLACK PATIENTS WITH KIDNEY TUMORS18
MP56-17 RADICAL CYSTECTOMY VIDEO CONSENSUS: A SIMPLE AND EFFECTIVE WAY TO IMPROVE AWARENESS OF PATIENTS UNDERGOING RADICAL CYSTECTOMY18
MP14-17 MORTALITY ASSOCIATED WITH SEPSIS POST-URETEROSCOPY AMONG A US-BASED COMMERCIAL POPULATION18
MP33-09 RADIOGENOMIC CORRELATES OF CLINICALLY RELEVANT CLEAR CELL RENAL CELL CANCER BIOMARKERS18
PD23-09 AUXETIC EXPANSION OF THE TUNICA ALBUGINEA FOR PENILE LENGTH AND GIRTH RESTORATION WITHOUT A GRAFT: A CASE SERIES.18
PD19-03 ASSESSMENT OF FACTORS INVOLVED IN LASER FIBER DEGRADATION WITH THULIUM FIBER LASER18
MP06-18 A GENOMIC URINE ASSAY TO DETECT URINARY TRACT RECURRENCES IN PATIENTS WITH BLADDER CANCER TREATED WITH RADIOTHERAPY17
MP24-13 IMPACT OF PRIMARY TUMOR SIZE ON CANCER-SPECIFIC AND ALL-CAUSE MORTALITY IN PATIENTS UNDERGOING CYTOREDUCTIVE NEPHRECTOMY FOR METASTATIC RENAL CELL CARCINOMA: ANALYSIS FROM THE INTERNATIONAL MA17
MP11-12 PRENATAL DIAGNOSIS OF BLADDER AND CLOACAL EXSTROPHY OVER 20 YEARS17
MP29-04 EFFECT OF SURGEON VOLUME AND FACILITY VOLUME ON OUTCOMES OF BENIGN PROSTATIC HYPERPLASIA SURGERY17
MP47-08 SURGICAL DELAY AFTER BIOPSY AND RISK OF UPSTAGING FOR CLINICAL T1A RENAL CELL CARCINOMA17
PD41-12 FROM BIOPSY TO DIAGNOSIS IN 30 MIN: REMOTE INSTANT PROSTATE PATHOLOGY BASED ON ARTIFICIAL INTELLIGENCE ENHANCED ULTRASOUND (AI-US)17
V11-06 DYNAMIC SENTINEL LYMPH NODE BIOPSY FOR PENILE CANCER: ACCURACY IS IN THE TECHNIQUE17
PD45-02 UROLIFT VERSUS REZUM FOR BENIGN PROSTATIC HYPERPLASIA: A REAL-WORLD SINGLE-INSTITUTION ANALYSIS17
MP56-19 TRIMODAL THERAPY VERSUS RADICAL CYSTECTOMY FOR T2 BLADDER CANCER: REAL-WORLD EVIDENCE FROM ONTARIO17
PD53-06 CHANGES IN MOUSE STOOL MICROBIOME WITH EXPOSURE TO BLADDER CARCINOGEN N-BUTYL-N-(4-HYDROXYBUYTL) NITROSAMINE (BBN): LONGITUDINAL ANALYSIS17
PD51-01 CONTEMPORARY SURGICAL OUTCOMES OF RETROPERITONEAL LYMPH NODE DISSECTION FROM THE SEMS TRIAL17
PD13-01 THE CONTINUING IMPACT OF THE COVID-19 PANDEMIC ON PROSTATE CANCER MANAGEMENT: A POPULATION BASED ANALYSIS17
Urological Oncology: Testis Cancer and Advances in Oncologic Therapy16
The Journal of Urology® Home Study Course 2022 Volume 207/20816
PD62-11 THERAPEUTIC EFFECT OF LIPOSOMAL DELIVERY OF HYDROGEN SULFIDE AND XENON ON ERECTILE FUNCTION AFTER CAVERNOUS NERVE INJURY16
Contemporary Outcomes of Patients with Nonmuscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Implications for Clinical Trial Design. Reply.16
Editorial Comment16
MP46-01 COLLABORATIVE RESILIENCE PROGRAM TO ENHANCE QUALITY OF LIFE FOR POST-PENECTOMY PATIENTS: DYADIC COPING PERSPECTIVE16
MP40-02 CAN THE PRESENTATION OF UPPER TRACT UROTHELIAL CANCER GUIDE US ON HOW TO IMAGE NON-VISIBLE HAEMATURIA?: A REVIEW OF 10 YEARS16
“Bottoms Up!”: A Toast to Reexamining the Debate of Top-Down vs Bottom-Up Approach for the Evaluation of Febrile Urinary Tract Infection16
Imaging16
V10-11 PARTIAL NEPHRECTOMY IN COMPLEX KIDNEY MASSES - TWO APPROACHES WITH THE DAVINCI SINGLE PORT ROBOT16
MP04-08 TRANEXAMIC ACID TO IMPROVE SAME-DAY DISCHARGE RATES AFTER HOLMIUM LASER ENUCLEATION OF THE PROSTATE: A RANDOMIZED, CONTROLLED PROSPECTIVE TRIAL16
LBA02-10 ASSESSING THE RISKS OF A POSITIVE URINE CULTURE IN UNCOMPLICATED RENAL COLIC PATIENTS16
Editorial Comment15
MP48-09 UPPER TRACT UROTHELIAL CARCINOMA FOLLOWING RADICAL CYSTECTOMY: A RISK-ADAPTED SCORING MODEL FOR STRATIFYING SURVEILLANCE INTENSITY15
Geriatrics15
PD51-11 CONCOMITANT VS STAGED LYMPHADENECTOMY IN CLINICALLY NODE-POSITIVE PENILE SQUAMOUS CELL CARCINOMA: RECURRENCE PATTERNS AND SURVIVAL OUTCOMES15
MP17-14 IDENTIFYING CRIBRIFORM PATTERN IN MPMRI SCANS FROM 3D RECONSTRUCTED RALP SPECIMENS USING DEEP LEARNING15
MP40-03 CIRCULATING CHROMOSOME CONFORMATION SIGNATURES ENHANCE THE ACCURACY OF PSA FOR DETECTING PROSTATE CANCER - RESULTS FROM PERFORMANCE OF THE EPISWITCH TM PCA T15
MP09-02 IS IT CLINICALLY AND ONCOLOGICALLY SAFE TO OMIT PROSTATE BIOPSY IN LOW RISK STRATIFIED PATIENTS?15
MP11-11 CHANGES TO INITIAL RISK ASSESSMENT AND INTENDED PATIENT MANAGEMENT IN HIGH-RISK PROSTATE CANCER: AN EXPLORATORY ANALYSIS OF COHORT A FROM THE OSPREY TRIAL15
MP59-17 DEVELOPMENT AND INTERNAL VALIDATION OF A PREDICTIVE MODEL FOR RECURRENCE-FREE SURVIVAL IN PTA LOW-GRADE BLADDER CANCER15
PD18-04 HAZARD OF DEATH IN VON HIPPEL-LINDAU DISEASE PATIENTS DEPENDS ON GENOTYPE AND ONSET AGE AS WELL AS FIRST AFFECTED LESION15
MP23-09 AN ANALYSIS OF THE TRENDS IN KIDNEY AND URETER STONE MANAGEMENT OVER THE PAST DECADE IN GERMANY, FRANCE AND ENGLAND15
MP27-09 OXYMATRINE IMPROVES ERECTILE FUNCTION THROUGH SUPPRESSION OF INFLAMMATION AND FIBROSIS IN DIABETIC RATS15
MP46-05 CHARACTERIZING ONLINE TESTICULAR CANCER DISCUSSIONS WITH QUANTITATIVE THEMATIC ANALYSIS15
MP63-12 UTILITY OF TRANSVAGINAL ULTRASOUND SHEAR WAVE ELASTOGRAPHY FOR INVESTIGATING THE POSTERIOR BLADDER WALL OF ACONTRACTILE BLADDER (ACB)/DETRUSOR UNDERACTIVITY (DU) IN WOMEN15
MP28-09 IMPACT OF SPIRITUALITY ON QUALITY OF LIFE IN LOW-INCOME MEN WITH PROSTATE CANCER15
PD26-10 COMPARISON OF INTRAVESICAL THERAPY AND SURGERY AS TREATMENT OPTIONS FOR RECURRENT BLADDER CANCER (CISTO): UPDATE ON AN ONGOING MULTICENTER PRAGMATIC STUDY15
MP06-15 VIRTUAL REALITY IMMERSION FOR REDUCING ANXIETY AND PAIN DURING TRANSPERINEAL PROSTATE BIOPSY: A PROSPECTIVE, RANDOMIZED CLINICAL TRIAL15
MP38-07 UPGRADING ON PER PROTOCOL VS FOR CAUSE SURVEILLANCE PROSTATE BIOPSIES: AN OPPORTUNITY TO DECREASING THE BURDEN OF ACTIVE SURVEILLANCE15
MP35-11 TRENDS AND INCIDENCE OF REPORTED EVENTS ASSOCIATED WITH URETERAL STENTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION'S MANUFACTURER AND USER FACILITY DEVICE EXPERIENCE DATABASE14
MP05-01 MICRO COMPUTED TOMOGRAPHY ANALYSIS OF MINERAL IN RENAL PAPILLAE SHOWS THAT RANDALL'S PLAQUE FORMATION OCCURS INDEPENDENTLY OF UPSTREAM DUCTAL PLUGGING IN THE MEDULLA14
MP06-20 SIGNIFICANT REDUCTION OF PERIOPERATIVE SERIOUS REPORTABLE EVENTS THROUGH A NOVEL SURGICAL SAFETY CHECKLIST AND TIME-OUT PROCEDURE14
PD24-07 FIRST ANALYSIS OF THE SAFETY AND EFFICACY OF UGN-101 IN THE TREATMENT OF URETERAL TUMORS14
MP71-18 PERIPHERAL TIBIAL NERVE STIMULATION DEMONSTRATES LIMITED IMPROVEMENT IN SELF-REPORTED SYMPTOMS FOR PATIENTS WITH OVERACTIVE BLADDER: SINGLE CENTER EXPERIENCE14
PD45-03 FACTORS AFFECTING HOLMIUM LASER INEFFICIENCY: COMPARISON OF LARYNGEAL MASK AIRWAY AND ENDOTRACHEAL TUBE USE DURING FLEXIBLE URETEROSCOPY FOR RENAL STONES14
MP53-05 RISK OF ACUTE KIDNEY INJURY AFTER LOWER URINARY TRACT RECONSTRUCTION WITH EARLY NSAID THERAPY: A PROPENSITY MATCHED RETROSPECTIVE ANALYSIS14
LBA02-12 IS LEARNING CURVE IMPORTANT WHILE PERFORMING PSMA-PET? ANALYSIS OF DETECTION RATE ACCORDING TO GLEASON SCORE AND PSA LEVEL IN TWO TIMEFRAMES AT A BRAZILIAN HIGH-VOLUME CENTER14
MP61-11 RETZIUS-SPARING ROBOT-ASSISTED RADICAL PROSTATECTOMY AFTER PREVIOUS TRANS-URETHRAL RESECTION OF THE PROSTATE: ASSESSMENT OF FUNCTIONAL AND ONCOLOGICAL OUTCOMES14
MP72-17 SURGEON’S PERSONAL OPIOID BEHAVIORS IMPACT POST-OPERATIVE PRESCRIBING FOR OUTPATIENT PROCEDURES14
MP15-09 TADALAFIL VERSUS COMBINED TAMSOLUSIN AND CIPROFLOXACIN FOR TREATMENT OF CHRONIC PELVIC PAIN SYNDROME: A RANDOMIZED CONTROLLED TRIAL14
MP58-04 PROPOSAL AND INTERNAL VALIDATION OF A NOMOGRAM FOR THE PREDICTION OF LOCAL RECURRENCE FREE-SURVIVAL AFTER PERCUTANEOUS ABLATION FOR CT1 RENAL MASSES14
MP74-18 DETRUSOR VOIDING CONTRACTION VELOCITY IS RELEVANT TO PATIENTS WITHOUT BLADDER OUTFLOW OBSTRUCTION14
MP75-10 SURVIVAL OUTCOMES BY RACE FOLLOWING MINIMALLY INVASIVE SURGICAL TREATMENT FOR UPPER TRACT UROTHELIAL CARCINOMA: AN ANALYSIS OF THE ROBUUST REGISTRY13
MP46-13 ROBOT-ASSISTED RADICAL CYSTECTOMY WITH INTRACORPOREAL PADUA ILEAL NEOBLADDER: LONG-TERM FUNCTIONAL OUTCOMES AND CONTINENCE PREDICTORS ASSESSMENT FROM A HIGH-VOLUME CENTER LARGE CONSECUTIVE SER13
PD15-04 PREDICTION OF PROSTATE CANCER SPECIFIC MORTALITY IN MEN UNDERGOING RADIOTHERAPY WITH OR WITHOUT HORMONAL TREATMENT, RISK STRATIFICATION BASED ON CLINICAL CHARACTERISTICS AND PSA TREATMENT RESP13
MP25-06 DEVELOPMENT OF A MULTI-INSTITUTIONAL, SIMULATION-BASED SURGICAL SKILLS BOOTCAMP FOR JUNIOR UROLOGY RESIDENTS13
PD25-05 CHRONIC EXPOSURE OF PHYSIOLOGICAL CONCENTRATION OF ARSENIC INDUCED BLADDER MALIGNANCY IN PRECLINICAL MODELS13
MP57-13 IS BIPOLAR ENUCLEATION OF THE PROSTATE AN EFFECTIVE AND COST-EFFICIENT ALTERNATIVE TO ROBOTIC SIMPLE PROSTATECTOMY?13
HF02-14 HERNIAS, HEALING, HAGIOGRAPHY: AN ANALYSIS OF ST. ARTEMIOS AND BYZANTINE INCUBATION RITUALS13
MP70-06 MATCHED ANALYSIS OF URINARY TRACT INFECTIONS AND READMISSIONS AFTER OPEN URETERONEOCYSTOSTOMY: DOES AGE MATTER?13
MP79-10 PHARMACOVIGILANCE ANALYSIS OF MELANOMA ADVERSE EVENTS IN MEN TREATED WITH SILDENAFIL FOR ERECTILE DYSFUNCTION13
MP44-08 RELATIONSHIP BETWEEN COVID 19 VACCINATION AND PSA LEVEL13
PD08-11 ACTIVE SURVEILLANCE VERSUS PRIMARY INTERVENTION FOR CLINICAL T1a KIDNEY TUMORS: TWELVE-YEAR EXPERIENCE OF THE DISSRM PROSPECTIVE COMPARATIVE STUDY13
MP47-03 TRENDS IN SBRT FOR INOPERABLE RENAL CELL CARCINOMA13
PD41-11 THE IMPACT OF PROSTATE VOLUMES (≤80 CC VS. > 80 CC) ON PERIOPERATIVE OUTCOMES AND RISK OF RETREATMENT IN PATIENTS UNDERGOING AQUABLATION: A SINGLE-CENTER STUDY13
MP03-19 ROLE OF MICROFIBRILLAR-ASSOCIATED PROTEIN 4 IN PARTIAL BLADDER OUTFLOW OBSTRUCTION-RELATED BLADDER FIBROSIS13
MP72-09 SELF-SCHEDULING IMPROVES QUALITY OF CARE FOR HOSPITAL DISCHARGE FOLLOW UP OF URINARY RETENTION PATIENTS13
PD10-10 IMPROVING PREDICTION OF LOCAL STAGE BY PSMA-PET. DEVELOPMENT OF A NOVEL INTEGRATED TOOL FOR EXTRACAPSULAR EXTENSION AND SEMINAL VESICLE INVASION COMBINING CLINICAL AND IMAGING FEATURES IN LOCA13
PD03-02 RACIAL DISPARITIES IN PROSTATE CANCER TREATMENT IN A MULTI-INSTITUTIONAL REGIONAL COLLABORATIVE13
PD23-06 12-MONTH INTERIM RESULTS OF THE MULTICENTER, PROSPECTIVE, SINGLE-ARM STUDY WITH THE ZENFLOW SPRING SYSTEM: A NOVEL MINIMALLY-INVASIVE TREATMENT FOR LUTS ASSOCIATED WITH BPH12
V02-06 A TECHNIQUE FOR COMBINED ROBOTIC SACROCOLPOPEXY AND VENTRAL MESH RECTOPEXY12
PD52-01 A PHASE 2 RANDOMIZED, PLACEBO-CONTROLLED CROSSOVER TRIAL TO EVALUATE SAFETY AND EFFICACY OF PLATELET-RICH PLASMA INJECTIONS FOR PEYRONIE'S DISEASE: CLINICAL TRIAL UPDATE12
PD33-09 PATHOLOGIC DOWN STAGING WITH NEOADJUVANT CHEMOTHERAPY AS A PREDICTOR OF ONCOLOGICAL OUTCOMES FOR UPPER TRACT UROTHELIAL CARCINOMA TREATED WITH NEPHROURETERECTOMY: A ROBUUST REGISTRY ANALYSIS12
MP36-19 DEVELOPMENT AND VALIDATION OF A NOVEL NOMOGRAM TO PREDICT LYMPH NODE INVASION IN UPPER TRACT UROTHELIAL CARCINOMA12
MP29-20 A PROSPECTIVE, SINGLE CENTER RANDOMISED CONTROLLED TRIAL COMPARING DUSTING AND FRAGMENTATION MODES OF THULIUM FIBER LASER IN RETROGRADE INTRARENAL SURGERY12
MP69-07 UROLOGIC COMPLICATIONS OF SODIUM-GLUCOSE CO-TRANSPORTER-2 (SGLT-2) INHIBITORS DIFFER BETWEEN DIABETIC MEN AND WOMEN12
MP43-19 NOVEL NANOPARTICLE COATINGS DEMONSTRATE ANTIBACTERIAL AND ANTIBIOFILM PROPERTIES AGAINST MULTIPLE UROPATHOGENS12
MP13-02 PATTERNS OF TELE-HEALTH USAGE AFTER THE COVID-19 PANDEMIC AMONG SURGICAL SPECIALTIES AND UROLOGY12
PD58-01 PREVALENCE AND SPECTRUM OF GERMLINE MUTATIONS IN PATIENTS WITH UPPER TRACT UROTHELIAL CARCINOMA12
MP14-10 PERIOPERATIVE OUTCOMES OF NEPHRECTOMY FOLLOWING IMMUNE CHECKPOINT INHIBITOR THERAPY: A MULTICENTER COLLABORATIVE STUDY12
MP26-04 HOW MIRABEGRON AFFECTS THE HUMAN URETER: AN IN VITRO STUDY12
PD33-10 ROBOT-ASSISTED PARTIAL NEPHRECTOMY WITH HUGO™ RAS SYSTEM: PERIOPERATIVE OUTCOMES AND TRIFECTA ACHIEVEMENT FROM THE LARGEST MULTICENTRIC SERIES12
PD18-09 THE ROLE OF CYTOREDUCTIVE NEPHRECTOMY IN CONTEMPORARY METASTATIC RENAL CELL CARCINOMA: AN OTHER-CAUSE MORTALITY MATCH POPULATION-BASED STUDY12
PD14-10 ENHANCED ANTITUMOR EFFECT OF THE COMBINATION OF BACILLE CALMETTE-GUÉRIN AND AN IMMUNE CHECKPOINT INHIBITOR IN BLADDER CANCER-ON-A-CHIP12
MP19-05 LEARNING CURVES OF FUSION-GUIDED BIOPSY AND ULTRASOUND PROSTATE SEGMENTATION: A SINGLE-CENTER STUDY INVOLVING 14 OPERATORS AND 1721 PATIENTS12
PD34-11 PROSTATE-SPECIFIC ANTIGEN KINETICS IN PATIENTS WITH ADVANCED PROSTATE CANCER TREATED WITH APALUTAMIDE: RESULTS FROM THE TITAN AND SPARTAN STUDIES12
MP22-01 HIGH RESOLUTION 3D T1-MAPPING OF PIG BLADDER WALL BY INTRAVESICAL CONTRAST ENHANCED MRI AT 3T12
MP69-05 DEVELOPING AN ANTIMICROBIAL IRRIGATION SOLUTION FOR ENDOUROLOGICAL PROCEDURES: EX VIVO EFFICACY AND IN VIVO SAFETY12
MP54-17 FOSTERING DIVERSITY IN UROLOGY: ADDRESSING ETHNIC DISPARITIES IN APPLICANT AND RESIDENT RECRUITMENT12
PD55-04 IS PERCUTANEOUS NEPHROLITHOTOMY EFFECTIVE AND SAFE IN INFANTS YOUNGER THAN 2 YEARS OLD? COMPARISON OF MINI AND STANDARD PERCUTANEOUS NEPHROLITHOTOMY?12
MP09-01 TEMPORAL TRENDS OF BPH MEDICATIONS AND PROCEDURES - CONTEMPORARY MEDICARE DATABASE ANALYSIS FROM 2013-202012
MP70-20 MORTALITY DISPARITIES AMONG ASIAN AMERICANS DIAGNOSED WITH UROLOGIC CANCER11
MP35-13 PREVALENCE, TRENDS, AND COSTS OF OFFICE-BASED AND AMBULATORY SURGERY CENTER-BASED DIAGNOSTIC CYSTOSCOPY IN THE UNITED STATES11
MP34-14 ASSOCIATION OF POPULATION-LEVEL SOCIAL DETERMINANTS OF HEALTH WITH UROLOGIC CANCER CLINICAL TRIALS AVAILABILITY11
MP03-13 ARTIFICIAL URETHRAL SPHINCTER PRESSURE REGULATING BALLOON AND CUFF VARIATIONS FOLLOWING DEVICE EXPLANTATION11
MP30-15 MACHINE LEARNING TO DISTINGUISH BENIGN AND MALIGNANT RENAL LESIONS BASED ON ROUTINE CT IMAGING11
PD28-11 O TO ZZZ's: INVESTIGATING THE RELATIONSHIP BETWEEN ORGASM AND SLEEP QUALITY IN WOMEN11
PD61-12 SAME-DAY DISCHARGE FOLLOWING ROBOTIC PROSTATECTOMY: STANDARDIZATION AND SAFETY EVALUATION11
PD55-09 THE BALL IS OUT OF OUR COURT: DOES MODERN PRIMARY CARE LITERATURE REFLECT THE AMERICAN UROLOGICAL ASSOCIATION CRYPTORCHIDISM GUIDELINES?11
MP76-02 EXPLORING THE EFFECTS OF AMNIOTIC BLADDER THERAPY ON FEMALE SEXUAL DYSFUNCTION IN INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME PATIENTS11
MP08-20 SIGNIFICANT DROP OF EARLY AND TWO-YR MORTALITY FOR BLADDER CANCER PATIENTS RECEIVING RADICAL CYSTECTOMY IN THE LAST 20 YEARS: SINGLE CENTER ANALYSIS11
MP31-07 PROSTATE EXTRACELLULAR VESICLES AND PREDICTION OF CLINICALLY SIGNIFICANT PROSTATE CANCER: A PROSPECTIVE SINGLE-INSTITUTION PILOT STUDY11
MP02-01 "DOCTOR 1 PUT ME IN TOUCH WITH A FORMER PATIENT... OF MY EXPERIENCE THROUGH IT, I THINK SHE HELPED ME THE MOST": PEER SUPPORT AS AN INVALUABLE RESOURCE IN THE SETTING OF BLADDER CANCER SURGERY11
V11-11 HUGO RAS SIMPLE PROSTATECTOMY SEC. MILLIN: STEP BY STEP SURGICAL PROCEDURE AND SET UP IN A THREE ARMS CONFIGURATION11
PD47-07 THE STUDY OF AUTOMATIC RECOGNITION OF STONE COMPONENTS USING DIGITAL IMAGES FROM INTRAOPERATIVE FLEXIBLE URETEROSCOPY11
MP21-06 USABILITY TESTING OF THE SET BRAVE GOALS APP, A CONTINENCE GOAL-SELECTION APP FOR CHILDREN WITH SPINA BIFIDA11
PD36-05 DEEP LEARNING PREDICTIVE MODEL FOR PROSTATE CANCER RECURRENCE USING CLINICAL AND HISTOLOGICAL DATA FROM THE TCGA DATABASE11
PD14-08 IDENTIFICATION OF A BLADDER CANCER SUBPOPULATION THAT MAY BENEFIT FROM DASATINIB11
MP32-17 LONG-TERM FOLLOW-UP AND SUCCESS RATE OF VENTRAL INLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY VS DORSAL ONLAY BUCCAL MUCOSAL GRAFT URETHROPLASTY FOR FEMALE URETHRAL STRICTURE DISEASE11
PD49-07 UTILITY OF TESTICULAR SHEAR-WAVE ELASTOGRAPHY IN THE EVALUATION OF PEDIATRIC PATIENTS WITH KLINEFELTER SYNDROME11
MP36-11 GERIATRIC NUTRITIONAL RISK INDEX AS A SIGNIFICANT PROGNOSTIC FACTOR IN PATIENTS WITH CLEAR-CELL RENAL CELL CARCINOMA11
MP63-07 THE BUTOX STUDY: THE ROLE OF THE GUT MICROBIOME AND BUTYRATE IN CALCIUM OXALATE KIDNEY STONE DISEASE11
0.079697132110596